Hypothesis

2 Matching Annotations

Jun 2024
molecular-cancer.biomedcentral.com molecular-cancer.biomedcentral.com

Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients

2
1. scibot 06 Jun 2024
  
  in Public
  
  RRID: CVCL_0007
  
  DOI: 10.1186/s12943-024-02034-7
  
  Resource: (JCRB Cat# IFO50038, RRID:CVCL_0007)
  
  Curator: @AniH
  
  SciCrunch record: RRID:CVCL_0007
  
  What is this?
  
  RRID:CVCL_0007 DOI:10.1186/s12943-024-02034-7
2. scibot 06 Jun 2024
  
  in Public
  
  RRID: CVCL_1426
  
  DOI: 10.1186/s12943-024-02034-7
  
  Resource: (ICLC Cat# HTL01015, RRID:CVCL_1426)
  
  Curator: @AniH
  
  SciCrunch record: RRID:CVCL_1426
  
  What is this?
  
  RRID:CVCL_1426 DOI:10.1186/s12943-024-02034-7
Visit annotations in context

Tags

RRID:CVCL_0007

RRID:CVCL_1426

DOI:10.1186/s12943-024-02034-7

Annotators

scibot

URL

molecular-cancer.biomedcentral.com/articles/10.1186/s12943-024-02034-7